Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)
Clinical trial NCT01345240 · COMPLETED
Trial details
- NCT number
- NCT01345240
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-17
- Primary completion
- 2013-01-09
- Enrollment
- 705
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.